GENEVA (AP) — In a story May 3, 2021, about U.S. biotech company Moderna planning to provide up to 500 million doses for the U.N.-backed COVAX program, The Associated Press reported erroneously that Sweden was going to donate 1 million AstraZeneca doses to India. The donation is to the COVAX program in general.
Before you consider Moderna, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moderna wasn't on the list.
While Moderna currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
